125 related articles for article (PubMed ID: 37483165)
1. REDD1 (regulated in development and DNA damage 1) modulates the glucocorticoid receptor function in keratinocytes.
Chudakova DA; Trubetskoy D; Baida G; Bhalla P; Readhead B; Budunova I
Exp Dermatol; 2023 Oct; 32(10):1725-1733. PubMed ID: 37483165
[TBL] [Abstract][Full Text] [Related]
2. PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
Agarwal S; Mirzoeva S; Readhead B; Dudley JT; Budunova I
EBioMedicine; 2019 Mar; 41():526-537. PubMed ID: 30737086
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy.
Baida G; Bhalla P; Yemelyanov A; Stechschulte LA; Shou W; Readhead B; Dudley JT; Sánchez ER; Budunova I
Oncotarget; 2018 Oct; 9(78):34772-34783. PubMed ID: 30410676
[TBL] [Abstract][Full Text] [Related]
4. The long winding road to the safer glucocorticoid receptor (GR) targeting therapies.
Lesovaya EA; Chudakova D; Baida G; Zhidkova EM; Kirsanov KI; Yakubovskaya MG; Budunova IV
Oncotarget; 2022; 13():408-424. PubMed ID: 35198100
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin Modulates Glucocorticoid Receptor Function, Blocks Atrophogene REDD1, and Protects Skin from Steroid Atrophy.
Lesovaya E; Agarwal S; Readhead B; Vinokour E; Baida G; Bhalla P; Kirsanov K; Yakubovskaya M; Platanias LC; Dudley JT; Budunova I
J Invest Dermatol; 2018 Sep; 138(9):1935-1944. PubMed ID: 29596905
[TBL] [Abstract][Full Text] [Related]
6. REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids.
Baida G; Bhalla P; Kirsanov K; Lesovaya E; Yakubovskaya M; Yuen K; Guo S; Lavker RM; Readhead B; Dudley JT; Budunova I
EMBO Mol Med; 2015 Jan; 7(1):42-58. PubMed ID: 25504525
[TBL] [Abstract][Full Text] [Related]
7. Sexual dimorphism in atrophic effects of topical glucocorticoids is driven by differential regulation of atrophogene REDD1 in male and female skin.
Baida G; Agarwal S; Readhead B; Dudley JT; Budunova I
Oncotarget; 2020 Jan; 11(4):409-418. PubMed ID: 32064044
[TBL] [Abstract][Full Text] [Related]
8. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
[TBL] [Abstract][Full Text] [Related]
9. Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.
Kishibe M; Baida G; Bhalla P; Lavker RM; Schlosser B; Iinuma S; Yoshida S; Dudley JT; Budunova I
Oncotarget; 2016 Oct; 7(43):69479-69488. PubMed ID: 27283773
[TBL] [Abstract][Full Text] [Related]
10. Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?
Zhidkova EM; Lylova ES; Grigoreva DD; Kirsanov KI; Osipova AV; Kulikov EP; Mertsalov SA; Belitsky GA; Budunova I; Yakubovskaya MG; Lesovaya EA
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077083
[TBL] [Abstract][Full Text] [Related]
11. A Novel Approach to Safer Glucocorticoid Receptor-Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition.
Lesovaya EA; Savinkova AV; Morozova OV; Lylova ES; Zhidkova EM; Kulikov EP; Kirsanov KI; Klopot A; Baida G; Yakubovskaya MG; Gordon LI; Readhead B; Dudley JT; Budunova I
Mol Cancer Ther; 2020 Sep; 19(9):1898-1908. PubMed ID: 32546661
[TBL] [Abstract][Full Text] [Related]
12. The mineralocorticoid receptor modulates timing and location of genomic binding by glucocorticoid receptor in response to synthetic glucocorticoids in keratinocytes.
Carceller-Zazo E; Sevilla LM; Pons-Alonso O; Chiner-Oms Á; Amazit L; An Vu T; Vitellius G; Viengchareun S; Comas I; Jaszczyszyn Y; Abella M; Alegre-Martí A; Estébanez-Perpiñá E; Lombès M; Pérez P
FASEB J; 2023 Jan; 37(1):e22709. PubMed ID: 36527388
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51.
Westberry JM; Sadosky PW; Hubler TR; Gross KL; Scammell JG
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):34-41. PubMed ID: 16723223
[TBL] [Abstract][Full Text] [Related]
14. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.
Spiegelman VS; Budunova IV; Carbajal S; Slaga TJ
Mol Carcinog; 1997 Sep; 20(1):99-107. PubMed ID: 9328440
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates.
Scammell JG; Denny WB; Valentine DL; Smith DF
Gen Comp Endocrinol; 2001 Nov; 124(2):152-65. PubMed ID: 11703081
[TBL] [Abstract][Full Text] [Related]
16. Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation.
Hinds TD; Stechschulte LA; Elkhairi F; Sanchez ER
Pharmacol Res Perspect; 2014 Dec; 2(6):e00076. PubMed ID: 25505617
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cells in the hair follicle bulge do not contribute to epidermal regeneration after glucocorticoid-induced cutaneous atrophy.
Chebotaev DV; Yemelyanov AY; Lavker RM; Budunova IV
J Invest Dermatol; 2007 Dec; 127(12):2749-58. PubMed ID: 17657244
[TBL] [Abstract][Full Text] [Related]
18. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
Sevilla LM; Pérez P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
[TBL] [Abstract][Full Text] [Related]
19. The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51.
Antunica-Noguerol M; Budziñski ML; Druker J; Gassen NC; Sokn MC; Senin S; Aprile-Garcia F; Holsboer F; Rein T; Liberman AC; Arzt E
Cell Death Differ; 2016 Oct; 23(10):1579-91. PubMed ID: 27177020
[TBL] [Abstract][Full Text] [Related]
20. Reversion of glucocorticoid-induced senescence and collagen synthesis decrease by LY294002 is mediated through p38 in skin.
Le QV; Wen SY; Chen CJ; Huang CY; Kuo WW
Int J Biol Sci; 2022; 18(16):6102-6113. PubMed ID: 36439879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
